ÃÞ»¨ÌÇÖ±²¥ COVID-19 Initiatives
As the COVID-19 pandemic evolves, ÃÞ»¨ÌÇÖ±²¥ is responding, from free access to coronavirus-related research from our journals, to advocating for the funding and resources we need to combat SARS-CoV-2. See what we're doing:
- Shaping the U.S. response.
- Leading on diagnostics & testing.
- Facilitating research.
- Providing trusted information.​
Shaping the U.S. Response
July 14, 2021: Don't Restrict Valid Pathogen Research, ÃÞ»¨ÌÇÖ±²¥ & Partners Warn Congress
July 8, 2021: ÃÞ»¨ÌÇÖ±²¥ Calls for Objective Evaluation into Pandemic Origins
March 26, 2021: ÃÞ»¨ÌÇÖ±²¥ Joins with Groups Calling for Equity in Vaccine Distribution
Feb. 27, 2021 : ÃÞ»¨ÌÇÖ±²¥ Hails the $1.75 Billion for Viral Sequencing in the American Rescue Plan Act Passed by the House
Feb. 11, 2021: ÃÞ»¨ÌÇÖ±²¥ and Stakeholders Endorse Tracking COVID-19 Variants Act
Feb. 10, 2021: ÃÞ»¨ÌÇÖ±²¥ Commends Congressional Proposal of $1.75 Billion for SARS-CoV-2 Sequencing
Feb 3, 2021: ÃÞ»¨ÌÇÖ±²¥ Responds to House Committee Hearing on COVID Response
Jan 21. 2021: First Steps by Administration Key to Getting Pandemic Under Control
Nov. 12, 2020: ÃÞ»¨ÌÇÖ±²¥ Urges Congress to Complete FY 2021 Appropriations Process
Oct 23, 2020: ÃÞ»¨ÌÇÖ±²¥ Advocates for Equitable Access to Future COVID-19 Vaccine
Oct 7, 2020: ÃÞ»¨ÌÇÖ±²¥ Statement on the FDA Guidance on EUAs for COVID-19 Vaccines
Sep. 17, 2020: ÃÞ»¨ÌÇÖ±²¥ Commends Senate for Advancing RISE Act
Aug. 24, 2020: ÃÞ»¨ÌÇÖ±²¥ Calls on Congress to Provide Relief for COVID-19
July 30, 2020: ÃÞ»¨ÌÇÖ±²¥ Thanks HHS for Renewing COVID-19 Public Health Emergency Declaration
July 20, 2020: ÃÞ»¨ÌÇÖ±²¥ and Partners Call for Reversal of Administration Policy Bypassing CDC on COVID-19
July 14, 2020: ÃÞ»¨ÌÇÖ±²¥ Defends Science-Based Health Policy in Letter to Executive Branch
June 23, 2020: ÃÞ»¨ÌÇÖ±²¥ and Stakeholders Urge HHS to Renew Public Health Declaration
June 23, 2020: ÃÞ»¨ÌÇÖ±²¥ Reiterates Need for High-Level Review of Coronavirus Response
June 23, 2020: ÃÞ»¨ÌÇÖ±²¥ Urges House Energy & Commerce Committee to Continue Efforts Toward Response and Recovery from the COVID-19 Pandemic
May 12, 2020: ÃÞ»¨ÌÇÖ±²¥ Statement in Response to Senate HELP Committee Hearing on COVID-19
April 24, 2020: ÃÞ»¨ÌÇÖ±²¥ Statement on the Paycheck Protection Program and Health Care Enhancement Act
April 21, 2020: ÃÞ»¨ÌÇÖ±²¥ Endorses Bipartisan Letter in Support of Emergency Funding for Research Labs in Next COVID-19 Package
March 30, 2020: ÃÞ»¨ÌÇÖ±²¥ Leads Stakeholder Letter Urging a Review of COVID-19 Response to Prepare for Future Pandemics
March 26, 2020: Breakdown of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
March: 17, 2020 ÃÞ»¨ÌÇÖ±²¥ Asks Congress for a High-Level, Comprehensive Review of the SARS-CoV-2 Response
March 4, 2021: ÃÞ»¨ÌÇÖ±²¥ Applauds Action on Coronavirus Emergency Supplemental Appropriation
March 3, 2020: ÃÞ»¨ÌÇÖ±²¥ Urges Senate Support for Coordinated Efforts to Combat COVID-19
Feb. 26, 2020: ÃÞ»¨ÌÇÖ±²¥ Issues Response to House Hearing on FY2021 HHS Budget and Coronavirus
Feb. 5, 2020: ÃÞ»¨ÌÇÖ±²¥ Responds to House Hearing on Wuhan Coronavirus
Leading on Diagnostics & Testing
March 4, 2021: Medical Microbiologist Lab Directors Needed to Run Clinical ÃÞ»¨ÌÇÖ±²¥ LaboratoriesFeb. 1, 2021: New GAO Report Points to Need to Address On-going Testing Challenges
Jan. 21, 2021: First Steps by Administration Key to Getting Pandemic Under Control
Dec. 2, 2020: ÃÞ»¨ÌÇÖ±²¥ Joins Letter to Biden Transition Team Highlighting Laboratory Supply Challenges
Nov. 9, 2020: Supply Shortages Impacting COVID-19 and Non-COVID Testing
Oct. 6, 2020: ÃÞ»¨ÌÇÖ±²¥ and Partners Call for Transparency Regarding COVID-19 Testing Supplies
Aug. 27, 2020: ÃÞ»¨ÌÇÖ±²¥ Statement in Response to Change in CDC COVID-19 Testing Guidelines
Aug. 25, 2020: ÃÞ»¨ÌÇÖ±²¥ Reiterates Need for Continued Reimbursement of COVID-19 Tests
July 10, 2020: ÃÞ»¨ÌÇÖ±²¥ Advocates for Increased Access to Testing Supplies and PPE
July 6, 2020: ÃÞ»¨ÌÇÖ±²¥ Applauds Introduction of the TEST Act
July 1, 2020: ÃÞ»¨ÌÇÖ±²¥ Statement on the Critical Role of Training Medical and Public Health Microbiologists in the Pandemic
June 24, 2020: Protocol to Verify Emergency Use Authorization (EUA) SARS-CoV-2 Antibody Tests
June 19, 2020: SARS-CoV-2: New Insights on Antibody Testing and RNA Testing
June 2, 2020: Small Study Demonstrates Sample Inactivation May Lead to SARS-CoV-2 False Negatives
May 4, 2020: ÃÞ»¨ÌÇÖ±²¥ Thanks FDA for Clarifying SARS-CoV-2 Serology Test Guidance
April 27, 2020:
April 21, 2020: ÃÞ»¨ÌÇÖ±²¥ Urges FDA to Affirm Role of Clinical Labs for COVID-19 Serology Testing
April 20, 2020:
April 17, 2020:
April 14, 2020: ÃÞ»¨ÌÇÖ±²¥ Submits Letter to FDA Calling for Stronger Oversight of COVID-19 Serology Tests
April 3, 2020: Protocol to Verify Emergency Use Authorization (EUA) COVID-19 Diagnostic Tests
March 27, 2020: The Value of Diagnostic Testing for SARS-CoV-2: When, Whom, What and How Often To Test?
March 17, 2020: ÃÞ»¨ÌÇÖ±²¥ Commends New Guidance to Increase COVID-19 Testing Capacity
March 11, 2020: A Possible Treatment for COVID-19 and an Approach for Developing Others
March 10, 2020: ÃÞ»¨ÌÇÖ±²¥ Expresses Concern ÃÞ»¨ÌÇÖ±²¥ Test Reagent Shortages
March 9, 2020: Expediting COVID-19 Testing and Expanding Access to Clinical Labs
Feb. 28, 2020: Amid COVID-19, ÃÞ»¨ÌÇÖ±²¥ Voices Concerns about Clinical Access to Tests
Feb. 3, 2020: Novel Coronavirus Lab Protocols and Responses: Next Steps
Facilitating Research
March 2, 2021: COVID-19 Spread Tracked via a Rapid, Large-scale Early Wastewater Surveillance Alert System
Feb. 24, 2021: How to Neutralize the SARS-CoV-2 Virus
Jan. 22, 2021: NSAIDs Might Exacerbate or Suppress COVID-19 Depending on Timing, Mouse Study Suggests
Jan. 19, 2021: Sequencing of Wastewater Useful for Control of SARS-CoV-2
Jan. 12, 2021: Poor Gut Health Connected to Severe COVID-19, New Review Shows
Nov. 23, 2020: We Need to Start Planning for a Post-COVID-19 Research Ecosystem Now
Oct. 30, 2020: Washing Hands and Halloween Candy can Mitigate COVID-19 Contamination Risks
Oct. 20, 2020: In Recovering COVID-19 Patients, Antibodies Fade Quickly
Oct. 9, 2020: New Study Suggests Crucial Role for Lymphocytes in Asymptomatic COVID-19 Infection
Oct. 8, 2020: Detecting SARS-CoV-2 in the Environment
Sept. 21, 2020: Researchers Find Diminished Response by Killer T Cells in Elderly COVID-19 Patients
Aug. 26, 2020: Neutralizing Antibodies Appear to Protect Humans From Coronavirus Infection
July 15, 2020: Obesity and Metabolic Syndrome are Risk Factors for Severe Influenza, COVID-19
July 14, 2020: Ups and Downs in COVID-19 Data may be Caused by Data Reporting Practices
June 25, 2020: Researchers Identify N95 Respirator Decontamination Method Using Microwave-Generated Steam
June 24, 2020: Asymptomatic COVID-19 Patients Also Contaminate the Environment
June 19, 2020: MMR Vaccine Could Protect Against the Worst Symptoms of COVID-19
May 4, 2020: Two Drugs Show Promise Against COVID-19
April 15, 2020: ÃÞ»¨ÌÇÖ±²¥ Launches a COVID-19 Research Registry
March 27, 2020: ÃÞ»¨ÌÇÖ±²¥ COVID-19 International Summit Sets Research Priorities
March 23, 2020: Antimicrobials and COVID-19: Strategies for Treating a Pandemic
March 23, 2020: Researchers Investigate Potential Treatments for COVID-19
Jan. 31, 2020: 2019 Novel Coronavirus (2019-nCoV) Update: Uncoating the Virus
Jan. 31, 2020:
Jan. 30, 2020: ÃÞ»¨ÌÇÖ±²¥ Provides Free Access to Coronavirus Research Articles
Providing Trusted Information
March 5, 2021: COVID-19 Vaccines Signal Light After Dark DaysMarch 3, 2021: SARS-CoV-2 Variants vs. Vaccines
Feb. 22, 2021: COVID-19 Vaccinations in Underrepresented Communities
Feb. 20, 2021: Tracking COVID-19 Variants: The Role of Advanced Molecular Detection and Genomic Surveillance
Jan. 12, 2021: Immunological Memory to SARS-CoV-2: Microbial Minutes
Dec. 16, 2020: COVID-19 Webinar: Revving Up to Warp Speed
Dec. 4, 2020:
Nov. 10, 2020: Asymptomatic SARS-CoV-2: Microbial Minutes
Oct. 27, 2020: COVID-19 and the Flu
Sept. 21, 2020: SARS-CoV-2 Reinfection: Microbial Minutes
May 27, 2020: Coronavirus Webinar Series: The Microbial Sciences Respond to COVID-19
May 20, 2020: ÃÞ»¨ÌÇÖ±²¥ Hosts COVID-19 Webinar with CDC
May 4, 2020: ÃÞ»¨ÌÇÖ±²¥ President Robin Patel addressed stakeholders on the weekly Centers for Disease Control and Prevention (CDC) Clinical Laboratory COVID-19 Response conference call. Her presentation discussed ÃÞ»¨ÌÇÖ±²¥'s response to date to the pandemic, including support for research, support for clinical microbiologists, and communication with policymakers, stakeholders and the public. Access the .
March 20, 2020: Top COVID-19 Questions, Answered: An Interview with ÃÞ»¨ÌÇÖ±²¥ President Robin Patel
Feb. 28, 2020: What to Know ÃÞ»¨ÌÇÖ±²¥ the New Coronavirus: An Interview with Dr. Stanley Perlman
Jan. 30, 2020: Anthony Fauci Addresses Coronavirus at ÃÞ»¨ÌÇÖ±²¥ Biothreats Conference